Page last updated: 2024-08-17

triiodothyronine and (2e,4e,6e,10e)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid

triiodothyronine has been researched along with (2e,4e,6e,10e)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Moriwaki, H; Muto, Y; Nakamura, N; Shidoji, Y1

Other Studies

1 other study(ies) available for triiodothyronine and (2e,4e,6e,10e)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid

ArticleYear
Apoptosis in human hepatoma cell line induced by 4,5-didehydro geranylgeranoic acid (acyclic retinoid) via down-regulation of transforming growth factor-alpha.
    Biochemical and biophysical research communications, 1996, Feb-06, Volume: 219, Issue:1

    Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Line; Cell Survival; Cells, Cultured; Epidermal Growth Factor; ErbB Receptors; Gene Expression Regulation; Humans; Insulin-Like Growth Factor II; Kinetics; Liver; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Polymerase Chain Reaction; RNA, Messenger; Time Factors; Transforming Growth Factor alpha; Tretinoin; Triiodothyronine; Tumor Cells, Cultured

1996